CYCA trading on the OTC and introducing the VeriSmartPhone™ application, online interactive and a HIPPA compliant patient/physician/health-plan administrator communication dashboard.

STOCK SYMBOL: CYCA

CYTTA CORPORATION

Hot Medical / Tech Stock!

BIG POTENTIAL.  BIGGER PARTNERS.

I would like to introduce you to Cytta Corp. (OTC:PINK: CYCA).  Cytta is a micro-cap penny stock at about 4 cents per share, with big potential and even bigger partners.  CYCA has now developed three digitally disruptive technologies, VeriSmartPhone™, SUPER™ Compression and Wi-VHFi™ broadband.  Utilizing its VeriSmartPhone™ technology CYCA has built the Doctor Direct telehealth system which they utilize for collecting medical information from home healthcare monitoring equipment.  The information is passed from the home monitoring equipment to a specially programmed mobile phone.  The VeriSmartPhone™ then transmits the information to a central database in the Cloud where it is stored and reported to healthcare providers.  The database monitors the results utilizing artificial intelligence, immediately notifying the patient’s doctor when the upper or lower limits are violated.  Others can provide similar functionality in a less direct fashion.  CYCA has the technology and licenses to offer this technology directly through any smartphone.  No app is necessary.  The Cytta instruction set can never be accidentally disabled making Cytta’s technology ideal for an older and/or sicker patient base.  The same VeriSmartPhone™ technology can also be used to monitor and report data coming from any sensors including pipelines, transportation systems, and inventory systems.  CYCA’s big partners include Oracle who recently agreed to partner with Cytta in engineering Cytta’s technology for large scale usage.

WHAT DOES ORACLE SEE IN CYCA?

·        Since Medicare and Medicaid began allowing doctors to bill for remote monitoring, there is now a funding source for this technology.

·        There is no industry standard for the data collection, storage and reporting.  Oracle sees Cytta as its last mile solution in creating a new industry standard.

·        As valuable as the medical results are to individual patients, the ‘big data’ possibilities in years to come could prove invaluable to medical care on a global basis.  Oracle’s role as the database and reporting provider offers some very interesting long term opportunities.

Next Phase

•             Oracle grew to where it is today through smart deals with long term growth.  The Oracle deal makes CYCA look like a valuable prospect to other giants.  Cytta and Oracle are currently in rollout discussions with a major cellular Carrier.

Growth in home Health Care

•             Professionals and investors in the health care services industry are optimistic about the industry’s performance and they’re particularly bullish about the growth of the home health and hospice sector in the coming year.